Quick Takeaways
- KINGDON CAPITAL MANAGEMENT, L.L.C. filed SCHEDULE 13G for enVVeno Medical Corporation Common Stock, $0.00001 par value (NVNO).
- Disclosed ownership: 7.1%.
- Date of event: 02 Sep 2025.
KINGDON CAPITAL MANAGEMENT, L.L.C. - 02 Sep 2025 SCHEDULE 13G Report for enVVeno Medical Corporation Common Stock, $0.00001 par value (NVNO)
- Filing Manager
- KINGDON CAPITAL MANAGEMENT, L.L.C.
- Reporting Manager
- Kingdon Capital Management, L.L.C.
- Symbol
- NVNO
- Shares outstanding
- 19,144,521 shares
- Disclosed Ownership
- 1,359,261 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G
- Filing time
- 09 Sep 2025, 12:58:26 UTC
- Date of event
- 02 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"KINGDON CAPITAL MANAGEMENT, L.L.C. disclosed 7.1% ownership in enVVeno Medical Corporation Common Stock, $0.00001 par value (NVNO) on 02 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Sep 2025, 12:58.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kingdon Capital Management, L.L.C. | 7.1% | 1,359,261 | 0 | 1,359,261 | /s/ Richard Weinstein | Richard Weinstein/Chief Operating Officer & General Counsel | |
| M. Kingdon Offshore Master Fund, L.P. | 6.6% | 1,265,845 | 0 | 1,265,845 | By: Kingdon GP, LLC, its general partner, By: /s/ Mark Kingdon | Mark Kingdon/Managing Member | |
| Kingdon GP, LLC | 6.6% | 1,265,845 | 0 | 1,265,845 | /s/ Mark Kingdon | Mark Kingdon/Managing Member | |
| Mark Kingdon | 7.1% | 1,359,261 | 0 | 1,359,261 | /s/ Mark Kingdon | Mark Kingdon |